Clinical Trial Update: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alvocidib, cytarabine, and mitoxantrone in adults with newly diagnosed acute myeloid leukemia shows results were posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)
• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7) | Phase 2 | Status: COMPLETED | Results posted: 2013-12-05